involvement should be considered when one examines young men with acne and arthritic symptoms.
Since there are few epidemiological data on this condition in the elderly, we undertook a study in 614 subjects (107 men and 507 women), all aged 70 or over, the average age being 83.9 years. The series comprised 126 hospitalized geriatric patients, 207 chronic invalids, 218 residents in retirement homes, and 63 patients from general practice. Neuroleptic treatment, generally using sedative drugs administered in low doses, had been used in 30.6% of all patients but in 41.1% of the chronic invalids; patients had not received anticholinergic drugs to counter extrapyramidal effects, but 23.3% of the entire group were taking benzodiazepines.
Careful clinical observation showed the presence of BLFD in 8.8% of cases, i.e. 54 patients (4 men and 50 women), though the disorder had in only a few cases been noted in the medical records. In the subgroups, the incidence of dyskinesia was 5.9% among individuals in retirement homes, 6 .3% in patients from general practice, 7 .9% in hospitalized subjects and as high as 13% in chronic invalids. The condition was clearly more frequent in women (9.9%) than in men (3.3%), but within the age group studied there was no further relationship to increasing age. A history of recent neuroleptic treatment was slightly but not significantly more common in subjects suffering from BLFD than in others. On the other hand, treatment with benzodiazepines was significantly more common (P < 0.01) in non-dyskinetic subjects (23.3%) than in dyskinetic subjects (16.7%).
Of the 54 cases of BLFD, 20 could be considered as spontaneous and 34 as tardive dyskinesias in patients receiving neuroleptics. Most cases were mild, only one being classified as severe. Dental problems (edentation, poorly fitting prostheses) were equally common in neuroleptic and spontaneous cases. The patients with BLFD who were receiving neuroleptics were all classified as suffering from tardive dyskinesia, and there was no predominance of any particular type of neuroleptic.
This study confirms some of the trends evident from the literature [1] [2] [3] , notably the high incidence of BLFD in the elderly and the role of certain risk factors (neuroleptic treatment even in low doses, dental problems). It indicates how commonly this type of dyskinesia may go unrecorded unless it is specifically looked for. Finally, our data point to some protective effect of benzodiazepines, an interesting finding in the light of current hypotheses as to the pathophysiology of tardive dyskinesias, which suggest a derangement of the GABA system.
